特集「膵島移植」
膵島移植：保険収載までの経緯と今後
2021 年 56 巻 2 号 p. 119-124
詳細
2021 年 56 巻 2 号 p. 119-124
Islet transplantation is a minimally invasive and safe therapy for type1 diabetes mellitus patients with severe hypoglycemic unawareness. Multicenter clinical trials in Japan have confirmed that islet transplantation is effective for restoration of hypoglycemic awareness and reduction in the glycated hemoglobin level. Based on the results of clinical islet transplantation to date, islet transplantation was covered by public medical insurance in April 2020. This paper introduces the process of medical insurance coverage and outlines the facility requirements for implementation as an insured medical treatment.
